Research

Overview

The Rao lab is focused on understanding the immune dysregulation that drives human autoimmune disease. We use a combination of high-dimensional analyses (RNA-seq, mass cytometry), cellular immunology, and murine models to identify and characterize T cell populations that are expanded in lupus, rheumatoid arthritis, and other autoimmune diseases.

Immunophenotyping to identify cellular drivers of autoimmunity in patients

We are using high dimensional cellular profiling to identify specific features of immune dysregulation that define axes of immune dysregulation in patients. We are using these approaches to 1) identify activated immune pathways that distinguish different autoimmune diseases, 2) identify cellular biomarkers that may predict response to biologic therapies, and 3) discover pathologic immune pathways activated in patients with rare or unusual autoimmune diseases.

Relevant papers
Mass cytometric profiling revealing outlier immune aberrations in undiagnosed patients
Immunofluorescence microscopy of RA synovium

Regulation and function of T peripheral helper (Tph) cells

T peripheral helper (Tph) cells infiltrate inflamed tissues, such as joints of patients with rheumatoid arthritis, and drive B cell responses through production of IL-21 and the B cell chemoattractant CXCL13. Tph cells functionally resemble Tfh cells in their ability to stimulate a B cell response, yet Tph cells express a distinct set of migratory receptors that enable their migration to inflamed tissues. These cells are expanded in many autoantibody-associated diseases. Using CRISPR/Cas9 screens, in vitro functional studies, and murine models, we are studying the signals that control both the B cell helper function and migratory capacity of these autoimmunity-associated T cells.

Relevant papers

Rao Lab

Brigham and Women's Hospital
Hale Building for Transformative Medicine
60 Fenwood Road
Boston, MA 02115